Screener
Haemonetics HAE Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Non-cash transfers from inventory to property, plant and equipment for Haemonetics equipment | (5,565) | (11,460) |
| Proceeds from sale of property, plant and equipment | 237 | 297 |
| Other investments | (9,000) | (18,083) |
| Net cash used in investing activities | (22,234) | (33,000) |
| Cash Flows from Financing Activities: | ||
| Payments on revolving credit facility | (50,000) | — |
| Repayment of term loan borrowings | (1,563) | (1,563) |
| Proceeds from employee stock purchase plan | 3,123 | 3,476 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's investing cash flow?
- Haemonetics (HAE) reported investing cash flow of -$22.23M in Q2 2026.
- How has Haemonetics's investing cash flow changed year-over-year?
- Haemonetics's investing cash flow increased by 32.6% year-over-year, from -$33M to -$22.23M.
- What is the long-term trend for Haemonetics's investing cash flow?
- Over 3 years (2022 to 2026), Haemonetics's investing cash flow has grown at a 27.6% compound annual growth rate (CAGR), from -$86.35M to -$179.55M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Haemonetics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude